Please use this identifier to cite or link to this item:
|Title:||Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system|
Faria, Tiago Q.
Brito, Rui M. M.
Gama, F. M.
|Keywords:||Protein delivery system|
|Journal:||International Journal of Pharmaceutics|
|Citation:||"International Journal of Pharmaceutics". ISSN 0378-5173. 400:1-2 (2010) 234-242.|
|Abstract(s):||Interleukin-10 (IL-10) is an anti-inflammatory cytokine, which active form is a non-covalent homodimer with two intramolecular disulphide bonds essential for its biological activity. A mutated form of murine IL-10 was successfully expressed in E. coli, recovered and purified from inclusion bodies. Its ability to reduce tumor necrosis factor synthesis and down-regulate class II major histocompatibility complex molecules expression on endotoxin-stimulated bone marrow-derived macrophages was confirmed, and shown to be similar to that of a commercially available IL-10. Given the potential of IL-10 for application in various medical conditions, it is essential to develop systems that can effectively deliver the protein. In this work it is shown that a dextrin nanogel effectively incorporate IL-10, stabilize, and enable the slow release of biologically active IL-10 over time. Altogether, these results demonstrate the suitability of dextrin nanogel to be used as a system for the controlled release of IL-10.|
|Appears in Collections:||CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series|
Files in This Item:
|Carvalho_International Journal of Pharmaceutics.pdf||731,42 kB||Adobe PDF||View/Open|